Recognizing and managing purple glove syndrome.
Snelson
C
C
School of Nursing, Kent State University, Ohio, USA.
Dieckman
B
B
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000191:economics; D018450:Disease Progression; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000150:complications*; D005260:Female; D006230:Hand Injuries / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D009460:Neurologic Examination / Q000379:methods; D009730:Nursing Assessment / Q000379:methods; D010347:Patient Care Planning; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D012307:Risk Factors; D017695:Soft Tissue Injuries / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D012995:Solubility; D012996:Solutions; D013577:Syndrome; D013997:Time Factors
D000927:Anticonvulsants; D012996:Solutions; D010672:Phenytoin; C043114:fosphenytoin